Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ericsson Venture Partners (EVP) was a venture capital firm established in 2000 as a joint venture between the Swedish telecommunications giant Ericsson, Merrill Lynch, Investor AB, and Industrivärden. The firm managed a $300 million fund primarily focused on early-stage and growth-stage investments in the communications technology sector, including mobile internet, network infrastructure, and wireless software. Operating out of Stockholm and New York, EVP aimed to capitalize on the rapid expansion of mobile connectivity and digital services. The firm was later succeeded by Eastven Venture Partners, which continued to manage the portfolio as an independent entity. While some industry databases may list broad sector interests, EVP's core business was centered on telecommunications and information technology rather than life sciences or biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ericsson Venture Partners.